CD4 and cancer: The results showed that ASB16-AS1 was positively correlated with B cells, T cells CD4+ and T cells CD8+ in most cancer types, and negatively correlated with dendritic celsl, macrophages and neutrophils in some cancer types (>14), especially neutrophils (Figure 5d).